23andme news - Search News

23andMe, Data Breach

23andMe Data Breach Exposes Millions: Is Your DNA at Risk?

In October 2023, 23andMe suffered a massive data breach that exposed the genetic information of millions of users. The breach, caused by a credential stuffing attack, has raised serious concerns about the security of sensitive DNA data entrusted to the company.

Reuters · 21h

Could 23andMe $30 million data breach settlement get derailed by mass arbitration?

A law firm representing about 5,000 23andMe customers who demanded arbitration after hackers obtained sensitive data from the genetic testing company told a California federal judge last week that it has serious qualms about a proposed $30 million class action settlement.

CNET on MSN · 12d

23andMe Agrees to $30M Settlement That Could Pay $10,000 to Data Breach Victims

Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed in the data breach.

KUTV · 14d

23andMe users with compromised data could claim part of $30 million settlement

Genetic testing company 23andMe has agreed to pay $30 million to settle a class action lawsuit stemming from a data breach in 2023.

Straight Arrow News on MSN · 13d

23andMe agrees to $30 million settlement after major data breach

Me has agreed to a $30 million settlement after a data breach exposed the personal information of 6.9 million customers.

23andMe no longer open to 3rd-party takeover bids - filing

Reuters on MSN · 18h

23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows

Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party takeover proposals for the company, a regulatory filing showed on Monday. "It has become even clearer to me that the best path forward for the (company) is for me to take the company private,

The Financial Times · 15h

Live news: 23andMe’s Anne Wojcicki rules out third-party takeover offers

It has become even clearer to me that the best path forward for the [company] is for me to take the company private,” Wojcicki said. In July, Wojcicki outlined a plan to acquire 23andMe’s outstanding shares for 40 cents a share and said she would consider takeover offers while evaluating such a deal.

Investing.com on MSN · 6h

23andMe no longer open to third-party takeover bids - filing

Chief Executive Officer Anne Wojcicki has ruled out the possibility that the DNA testing group would be open to third-party takeover offers, according to a regulatory filing on Monday. Wojcicki said she

46m

The 23andMe Genetic Testing Kit Is 50% Off For Prime Members Only

Get meaningful genetic insights, connect with your ancestry and learn how to make health-conscious decisions based on your ...

23andMe's Anne Wojcicki now says her take-private plan is the best option for company

"Whether I would ultimately accept such a proposal remained within my discretion," Wojcicki said in Monday's filing. "In the ...

Remember That DNA You Gave 23andMe?

DNA might contain health information, but unlike a doctor’s office, 23andMe is not bound by the health-privacy law HIPAA. And ...

With 23andMe in crisis, strengthening DNA security has never been more urgent

With all seven independent directors resigning from 23andMe millions of customers are questioning how the company plans to ...

WGN Radio19h

23andMe up for is up sale, where will our DNA go?

Kristen V. Brown, a staff writer at The Atlantic, joins host Lisa Dent to discuss the concerns and issues with 23andMe on the verge of bankruptcy and collapse. What does that mean for their ...

23andMe Board Quits As CEO Of DNA Testing Company Plans To Go Private

The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.

11don MSN

23andMe directors resign as the CEO of the genetic-testing company seeks to take it private

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

11don MSN

What happened to 23andMe?

The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...

ME INVESTOR ALERT: 23andMe Holding Co. Shareholders are Urged to Contact BFA Law about Investigation into the Company

September 30, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of directors and the co-founder ...

STAT6d

The science behind Summit’s success, 23andMe’s fate, and more biotech news updates

Amgen's immunology drug results —The Novo Nordisk Senate hearing —Sanofi's soul-searching Read on to learn more.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Related topics